Close Menu

NEW YORK (GenomeWeb) – Advanced Biological Laboratories today announced it has signed an agreement with University Hospitals Case Medical Center to collaborate on designing and validating a next-generation sequencing assay to detect drug resistance in HIV patients.

As part of the agreement, University Hospitals will use ABL's DeepChek software to analyze Deepgen HIV, a diagnostic test developed at Case Western Reserve University.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Harvard University professor has been charged with making false claims regarding funds he received from China, the New York Times reports.

Nature News reports that a US panel is reviewing current guidelines for federally funded gain-of-function viral research.

Discover magazine reports that animal dissections might dissuade students from science careers, but that a firm has developed synthetic frogs for dissections.

In PNAS this week: de novo mutation patterns among the Amish, an alternative RNA-seq method, and more.